Alexion Pharmaceuticals Inc. Bottom Line Advances 20% In Q4

Thursday, 16 February 2017
WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals Inc. (ALXN) announced a profit for its fourth quarter that increased compared to the same period last year.The company said its bottom line totaled $...

Related Videos


Market News Video -   ▶  01:19

Advertisement

You might like